Reply to Robert J. van Soest and Ronald de Wit's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033

被引：1

作者：

de Bono, Johann ^{[1
,2
]}

机构：

[1] Inst Canc Res, Sycamore House,Downs Rd, Sutton SM2 5PT, Surrey, England

[2] Royal Marsden Hosp, Sycamore House,Downs Rd, Sutton SM2 5PT, Surrey, England

来源：

EUROPEAN UROLOGY | 2017年 / 71卷 / 01期

关键词：

D O I：

10.1016/j.eururo.2016.10.005

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：E11 / E11

页数：1

共 21 条

[1] Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
Roviello, Giandomenico
Generali, Daniele
Petrioli, Roberto
[J]. EUROPEAN UROLOGY, 2017, 71 (02) : E55 - E55
[2] Re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
van Soesta, Robert J.
de Wit, Ronald
[J]. EUROPEAN UROLOGY, 2017, 71 (01) : E9 - E10
[3] Reply to Giandomenico Roviello, Daniele Generali, and Roberto Petrioli's Letter to the Editor re: Johann S. de Bono, Matthew R. Smith, Fred Saad, et al. Subsequent Chemotherapy and Treatment Patterns After Abiraterone Acetate in Patients with Metastatic Castration-resistant Prostate Cancer: Post Hoc Analysis of COU-AA-302. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.06.033
de Bono, Johann S.
[J]. EUROPEAN UROLOGY, 2017, 71 (02) : E56 - E56
[4] Re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035 Corticosteroid-associated Adverse Events in Elderly Patients
Roviello, Giandomenico
Bottini, Alberto
Generali, Daniele
[J]. EUROPEAN UROLOGY, 2016, 70 (02) : E41 - E41
[5] Re: Sanoj Punnen, Matthew R. Cooperberg, Anthony V. D'Amico, et al. Management of Biochemical Recurrence After Primary Treatment of Prostate Cancer: A Systematic Review of the Literature. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2013.05.025
Parker, Chris
Sydes, Matthew R.
Kynaston, Howard
[J]. EUROPEAN UROLOGY, 2013, 64 (05) : E102 - E102
[6] Reply to Giandomenico Roviello, Alberto Bottini, and Daniele Generali's Letter to the Editor re: Karim Fizazi, Kim N. Chi, Johann S. de Bono, et al. Low Incidence of Corticosteroid-associated Adverse Events on Long-term Exposure to Low-dose Prednisone Given with Abiraterone Acetate to Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.02.035. Corticosteroid-associated Adverse Events in Elderly Patients
Fizazi, Karim
De Porre, Peter
Londhe, Anil
McGowan, Tracy
Ryan, Charles J.
[J]. EUROPEAN UROLOGY, 2016, 70 (02) : E42 - E42
[7] Reply to Urmila Dhakad and Bhupendra Pal Singh's Letter to the Editor re: Dean A. Tripp, J. Curtis Nickel, Jennifer Wong, et al. Mapping of Pain Phenotypes in Female Patients with Bladder Pain Syndrome/Interstitial Cystitis and Controls. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.05.023
Tripp, Dean A.
[J]. EUROPEAN UROLOGY, 2012, 62 (04) : E74 - E74
[8] Reply to Johann S. de Bono, Maha Hussain, and Jinyu Kang's Letter to the Editor re: Konrad H. Stopsack. Efficacy of PARP Inhibition in Metastatic Castration-resistant Prostate Cancer is Very Different with Non-BRCA DNA Repair Alterations: Reconstructing Prespecified Endpoints for Cohort B from the Phase 3 PROfound Trial of Olaparib. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.09.024
Stopsack, Konrad H.
[J]. EUROPEAN UROLOGY, 2021, 79 (03) : E81 - E82
[9] Reply to Ferhat Ates, Ilker Akyol and Hasan Soydan's Letter to the Editor re: Meelan Bul, Xiaoye Zhu, Antti Rannikko, et al. Radical Prostatectomy for Low-Risk Prostate Cancer Following Initial Active Surveillance: Results from a Prospective Observational Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2012.02.002
Bul, Meelan
Zhu, Xiaoye
Roobol, Monique J.
[J]. EUROPEAN UROLOGY, 2012, 62 (01) : E10 - E11
[10] Reply to Glen Denmer Santok and Koon Ho Rha's Letter to the Editor re: Par Stattin, Fredrik Sandin, Frederik Birkebaek Thomsen, et al. Association of Radical Local Treatment with Mortality in Men with Very High-risk Prostate Cancer: A Semiecologic, Nationwide, Population-based Study. Eur Urol. In press. http://dx.doi.org/10.1016/j.eururo.2016.07.023
Stattin, Par
Bratt, Ola
[J]. EUROPEAN UROLOGY, 2017, 71 (04) : E115 - E116

← 1 2 3 →